Aside from the AKT1’s well-documented role in promoting cancer survival, emerging evidence implicates AKT1 in reducing the expression and impeding the nuclear accumulation of β-catenin, consequently reducing invasive potential [65,66]. Here, AKT1 is linked to cancer.